证券记录 · 已归档季度
RVMD
Revolution Medicines, Inc. · Healthcare · Biotechnology
20被追踪持有人
+3Δ持有人
68.96M持有股份
$3.10B报告持仓市值
+3新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +17.6% ·
股份流向 -0.6% ·
净新建仓位 +10.0%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 2.20M | $451.04M | n/a | −2 |
| Q2 2026 | 147 | +17 | 106.54M | $18.58B | +25 | −9 |
| Q1 2026 | 134 | +17 | 103.45M | $9.43B | +22 | −6 |
| Q4 2025 | 116 | +1 | 107.70M | $8.12B | +3 | −1 |
| Q3 2025 | 20 | +3 | 68.96M | $3.10B | +3 | −1 |
| Q2 2025 | 15 | 0 | 63.88M | $2.26B | n/a | n/a |
| Q1 2025 | 12 | +2 | 32.32M | $1.05B | +2 | n/a |
| Q4 2024 | 10 | -1 | 33.19M | $1.34B | n/a | −1 |
| Q3 2024 | 10 | -1 | 26.28M | $1.08B | n/a | −1 |
| Q2 2024 | 11 | n/a | 28.23M | $999.53M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 15.66M | -0.6% | $731.47M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | Wellington Management ✦ | 9.81M | -4.3% | $458.29M | 0.1% | ▼ Trim | 6 | SEC ↗ ×9 |
| 3 | Fidelity (FMR) ✦ | 9.40M | +12.9% | $439.06M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 4 | BlackRock ✦ (被动) | 8.33M | -3.9% | $388.91M | 0.0% | ▼ Trim | 2 | SEC ↗ ×16 |
| 5 | State Street Global Advisors ✦ (被动) | 5.25M | +11.3% | $245.39M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | JPMorgan Chase ✦ | 5.00M | n/a | $233.34M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 7 | T. Rowe Price ✦ | 4.47M | -15.7% | $181.08M | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
| 8 | Geode Capital Management ✦ (被动) | 3.15M | +5.1% | $146.93M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Morgan Stanley ✦ | 1.43M | n/a | $67.00M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 10 | Citadel Advisors ✦ | 1.18M | -20.1% | $55.11M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 11 | D. E. Shaw & Co. ✦ | 2.27M | +7.2% | $38.37M | 0.0% | ▲ Add | 6 | SEC ↗ ×3 |
| 12 | Adage Capital Partners ✦ | 1.24M | +38.4% | $34.82M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 13 | Goldman Sachs Group ✦ | 738.03K | n/a | $34.47M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 14 | Millennium Management ✦ | 428.31K | -69.0% | $20.00M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 253.10K | +3.9% | $11.82M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Marshall Wace ✦ | 161.10K | +482.0% | $7.52M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 17 | Gotham Asset Management ✦ | 99.11K | 新增 | $4.63M | 0.0% | New | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 70.29K | +368.1% | $3.24M | 0.0% | ▲ Add | 6 | SEC ↗ ×3 |
| 19 | Two Sigma Investments ✦ | 9.11K | 新增 | $425,297 | 0.0% | New | 1 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 7.30K | 新增 | $341,143 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Gotham Asset Management | $4.63M | 0.0% |
| Two Sigma Investments | $425,297 | 0.0% |
| Fisher Asset Management | $341,143 | 0.0% |
已清仓
| Norges Bank | $62.58M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 509 持有人, 197.96M 股份, $18.53B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 25
Cislini Jeff
Officer · 765 股 · $158,600
Sep 25
Mancini Anthony
Officer · 3.12K 股 · $625,885
Sep 24
Mancini Anthony
Officer · 587 股 · $117,400
Sep 22
ANDERSON ELIZABETH M
Director · 910 股 · $174,585
Sep 22
ANDERSON ELIZABETH M
Director · 4.99K 股 · $959,805
Sep 22
ANDERSON ELIZABETH M
Director · 1.50K 股 · $291,883
Sep 22
ANDERSON ELIZABETH M
Director · 100 股 · $19,515
Sep 22
ANDERSON ELIZABETH M
Director · 2.65K 股 · $512,227
Sep 18
Mancini Anthony
Officer · 1.76K 股 · $347,402
Sep 16
GOLDSMITH MARK A
Officer, Director · 13.78K 股 · $2.75M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G: BAKER BROS. ADVISORS LP
Aug 13
SC 13G: Janus Henderson Group Ltd.
Aug 13
SC 13G/A: FARALLON CAPITAL MANAGEMENT, L.L.C.
Jul 29
SC 13G: BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据